Jim Waldvogel - Marcus MD Downtown
| MCS Stock | USD 22.64 0.16 0.71% |
Insider
Jim Waldvogel is MD Downtown of Marcus
| Address | 100 East Wisconsin Avenue, Milwaukee, WI, United States, 53202-4125 |
| Phone | 414 905 1000 |
| Web | https://www.marcuscorp.com |
Marcus Management Efficiency
The company has Return on Asset of 0.0106 % which means that on every $100 spent on assets, it made $0.0106 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0218) %, meaning that it generated no profit with money invested by stockholders. Marcus' management efficiency ratios could be used to measure how well Marcus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.1 in 2024. Return On Capital Employed is likely to gain to -0.14 in 2024. At this time, Marcus' Non Currrent Assets Other are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 28.6 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 680.1 M in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennie Reilly | Comtech Telecommunications Corp | N/A | |
| Yelena Simonyuk | Comtech Telecommunications Corp | N/A | |
| Kimberly Pope | ADC Therapeutics SA | 57 | |
| Thomas Rinderknecht | ADC Therapeutics SA | 67 | |
| Anshuman Mehrotra | Belden Inc | 53 | |
| Mitchell Walorski | CTS Corporation | N/A | |
| Peter Greaney | ADC Therapeutics SA | 41 | |
| Kevin Maczka | Belden Inc | N/A | |
| Leah Tate | Belden Inc | 47 | |
| Ashish Chand | Belden Inc | 49 | |
| Thomas White | CTS Corporation | 38 | |
| Joseph Camardo | ADC Therapeutics SA | 71 | |
| MS MBA | ADC Therapeutics SA | 51 | |
| Colonel Atcheson | Comtech Telecommunications Corp | N/A | |
| Richard Onyett | ADC Therapeutics SA | 73 | |
| Robert Schmidt | ADC Therapeutics SA | 43 | |
| Jacques Theurillat | ADC Therapeutics SA | 62 | |
| Amanda Hamilton | ADC Therapeutics SA | N/A | |
| Gregory McCray | Belden Inc | 57 | |
| Ye Li | CTS Corporation | 53 | |
| Susan Romanus | ADC Therapeutics SA | 59 | |
Management Performance
| Return On Equity | -0.0218 | ||||
| Return On Asset | 0.0106 |
Marcus Leadership Team
Elected by the shareholders, the Marcus' board of directors comprises two types of representatives: Marcus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Marcus. The board's role is to monitor Marcus' management team and ensure that shareholders' interests are well served. Marcus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Marcus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Milstein, Independent Director | ||
| Brian Stark, Independent Director | ||
| Rolando Rodriguez, Executive Vice President of The Marcus Corporation and Chairman, President and Chief Executive Officer of Marcus Theatres Corporation | ||
| Allan Selig, Independent Director | ||
| John Murray, VP HR | ||
| Timothy Hoeksema, Independent Director | ||
| Chad Paris, Controller, Treasurer | ||
| Stephen Marcus, Chairman of the Board | ||
| Steve Martin, Chief Human Resource Officer | ||
| Steven Martin, Chief Officer | ||
| Steven Bartelt, Director Secretary | ||
| Michael Evans, President of Marcus Hotels & Resorts | ||
| Thomas Kissinger, Senior Executive Vice President, General Counsel, Secretary | ||
| Mark Gramz, President Corporation | ||
| Douglas Neis, Chief Financial Officer, Executive Vice President, Treasurer | ||
| David Baum, Independent Director | ||
| Gregory Marcus, President, Chief Executive Officer, Director | ||
| Skip Harless, Managing Resorts | ||
| Jim Waldvogel, MD Downtown | ||
| Diane Gershowitz, Director | ||
| Katherine Gehl, Independent Director | ||
| Mrs Lueck, Chief Officer | ||
| Andrew Flack, Chief Commercial Officer | ||
| Bruce Olson, Director |
Marcus Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Marcus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0218 | ||||
| Return On Asset | 0.0106 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 1.05 B | ||||
| Shares Outstanding | 24.5 M | ||||
| Shares Owned By Insiders | 5.34 % | ||||
| Shares Owned By Institutions | 82.89 % | ||||
| Number Of Shares Shorted | 970.47 K | ||||
| Price To Earning | 21.73 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Marcus Stock Analysis
When running Marcus' price analysis, check to measure Marcus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marcus is operating at the current time. Most of Marcus' value examination focuses on studying past and present price action to predict the probability of Marcus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marcus' price. Additionally, you may evaluate how the addition of Marcus to your portfolios can decrease your overall portfolio volatility.